메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
김지혜 (건강보험심사평가원) 엄혜은 (건강보험심사평가원) 윤정영 (건강보험심사평가원) 변지혜 (건강보험심사평가원)
저널정보
한국보건의료기술평가학회 보건의료기술평가 보건의료기술평가 제11권 제1호
발행연도
2023.6
수록면
26 - 36 (11page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objectives: This study aims to compare the domestic and foreign high-priced drug benefit management systems in order to draw implications for the development of the domestic system. Methods: In this study, countries with public health insurance systems and comparable demographic and economic characteristics were carefully chosen. A thorough literature review was conducted to examine the existing state of high-priced drug benefit management systems, and subsequently compare them to the Korean system in terms of access and financial management. Results: We examined the reimbursement systems for high-cost drugs in the United Kingdom, Germany, France, and Italy. These countries commonly utilized the managed entry agreement (MEA) or managed access agreement (MAA), rather than relying solely on specific pricing criteria. To enhance access, specific measures are implemented in each country as follows: the United Kingdom (Patient Access Schemes), Germany (Early Benefit Assessment), France (Autorisation Temporaire d’Utilisation), and Italy (the 5% AIFA Fund). Regarding fiscal management, MEAs/MAAs are also utilized to implement price discount, refund and aggregate limitations based on pharmaceutical companies’ sales. Simultaneously, a performance- based payment system is applied to high-priced drugs with significant clinical uncertainty. Conclusion: The reimbursement systems for high-cost drugs in major countries and Korea exhibit no significant differences. However, it should be noted that the MAA contract clause in the UK and Italy require pharmaceutical companies to supply free medicines to patients facing difficulties in receiving benefits. In the future, it is imperative for stakeholders to collaborate in establishing a patient support system.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0